Clonidine Plus Haloperidol in the Treatment of Schizophrenia/Psychosis
James W. Maas(University of California, San Francisco), C.L. Bowden(The University of Texas Health Science Center at San Antonio), Janet E. True(San Antonio State Chest Hospital), J.Arturo Silva(The University of Texas at San Antonio Health Science Center), Janet L. Tekell(The University of Texas at San Antonio Health Science Center), Nancy Berman(The University of Texas at San Antonio Health Science Center), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Alexander L. Miller(Northwell Health), Linda G. Funderburg(The University of Texas at San Antonio Health Science Center)
Cited by 17
Related Papers
Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
|American Journal of Psychiatry|2015|849
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325